Introduction
Transmissible spongiform encephalopathies (TSEs) encompass mainly Creutzfeldt-Jakob disease (CJD) in humans (Creutzfeldt, 1920; Jakob, 1921) , scrapie in sheep and goats (Cuill6 & Chelle, 1936) , bovine spongiform encephalopathy (BSE) (Wells et al., 1987) , transmissible mink encephalopathy (Marsh et al., 1969) and chronic wasting disease of mule deer and elk (Williams & Young, I980) . As the aetiology of TSEs remains unknown, their diagnosis relies on their transmissibility and pathological and molecular hallmarks. Vacuolar degeneration of the neuropil and neuronal cell bodies is the most characteristic histopathological lesion; it is accompanied Author for correspondence: C. I. LasmEzas.
Fax + 33 1 46 54 77 26, e-mail lasmezas@dsvidf.cea,fr by gliosis, i.e. hypertrophy and possible proliferation of astrocytes (Fraser, 1976) . The most specific molecular feature is the accumulation in the brain (Prusiner, 1982) and some peripheral organs (Doi et al., 1988; Farquhar et al., 1994) of an abnormal isoform of the host-encoded PrP protein, which copurifies with infectivity (Bolton et al., 1982; McKinley et al., 1983) . The pathological isoform has been named PrP se for scrapie, or PrP res for its enhanced resistance to proteases (Bolton et al., 1982; Prusiner et al., 1983) . A number of other proteins including glial markers and cytokines (Diedrich et al., 1991; Williams eta] ., 1994a, b) are hyperexpressed in the brains of affected animals, the most important of which is the astrocyte-specific glial fibrillary acidic protein (GFAP) (Dormont et al., 1981; Jendroska et al., 1991) . In contrast to PrP (Chesebro et al., 1985 ; Oesch et al., 1985) , the accumulation of GFAP is accompanied by the GFAP gene hyperexpression (Dormont et aI., 1989) . GFAP is a reliable marker for astrocytic activation (Kretzschmar et aI., 1985; Le Prince et al., 1993) .
In the hamster scrapie model inoculated by the intracerebral route, PrP res accumulation has been found to precede GFAP rise by 5 to I5 days (DeArmond eta]., 1989; Jendroska et a]., 1991) and detectable light microscopic pathology by about 14 days (Bolton et al., I991) . Qualitative immunohistochemical studies in the mouse scrapie model showed that earliest PrP res accumulation predates the development of vacuolar degeneration by several weeks and occurs in the same brain areas (Bruce et al., 1989) . This suggests a cause-effect relationship between the accumulation of PrP res and the focal development of astrogliosis and brain lesions.
The remarkable precise targeting of agent replication and the constant and repeatable timing of molecular and pathological events are central to the understanding of TSE pathogenesis. However, these depend on two main factors. One factor is linked to the agent: a number of agent strains derived from sheep and cows have been isolated in rodents and are characterized by different incubation periods, physical properties and the severity and distribution of pathological changes in the brain Dickinson et aI., 1989) . On the other hand, the Sinc gene in mice, which is very likely to be identical to the gene encoding PrP, plays a major role in the species barrier, the susceptibility, the incubation period and the distribution of brain pathology (Carlson et al., 1988; Fraser, 1993; Scott et aI., 1989) . The use of congenic mice has clearly shown that the distribution of vacuolar degeneration in the brain depends mainly on the scrapie strain but is also influenced by the PrP gene (Bruce et al., 199i) . The location of PrP mRNA and protein expression in the brain is independent of the PrP allele and remains unchanged after infection with two different scrapie strains (Manson et a]., 1992) . On the contrary, the regional pattern of PrP res accumulation, assessed by immunohistochemistry at the terminal stage of disease, varies with the PrP genotype of the mice and the strain of agent (Manson et al., I992) .
We used a kinetic and quantitative approach to study the interrelations between pathogenic events in the brain throughout TSE infection and to characterize which depend on the accumulation of the host-derived PrP re~ and which are strainspecific.
The outbreak of BSE and the infection of about 150000 cows in the UK motivated the study of the molecular features of the infection with BSE in a stabilized murine model. Transmission studies conducted in several mouse genotypes strongly suggested that the natural disease was caused by a single strain, different from any other sheep source tested (Bruce et al., 1994; Fraser et al., 1992) .
Therefore, the BSE agent was contrasted with scrapie to draw a precise kinetic comparison of the sequence of accumulation of the two major molecular hallmarks of infection, PrP res and GFAP, and the histopathological changes, in a single mouse genotype. We used two different routes of infection to have a better assessment of pathogenesis.
Methods
• Animals and agent strains. The murine C506M3 scrapie agent strain derived from sheep scrapie has been kindly provided by P. Brown (NIH, Bethesda, USA) and has a history of six passages in our laboratory. The mean incubation period has been calculated as the interval between inoculation and death or in extremis stage (Dickinson et al., I989) . The 4PB1 BSE strain results from the fourth passage into the C57BL/6 mouse of a pooled BSE cattle brain homogenate kindly provided by R. Bradley (Central Veterinary Laboratory, Weybridge, UK). It is likely to be very close to the 301C stabilized BSE strain obtained by the Neuropathogenesis Unit of ~he Institute for Animal Health in the UK (Bruce el a]., 1994).
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For sequential sacrifice, 50 weanling female C57BL/6 mice (R. Janvier, Le Genest-Saint-Isle, France) were inoculated intracerebrally (i.c.) with 20 ~I of a 1% 3PBl-infected brain homogenate and 50 mice were similarly inoculated with C506M3 brain homogenate. Twenty-five mice were inoculated intraperitoneally (i.p.) with each agent strain, by means of 100 lal of a 0"2 % brain homogenate, in order to equal the amount of agent with the i.c. experiment. Normal mouse brain was used for shaminfection of 10 mice i.c. and 10 mice i.p.
• $amplin 9 of material. For the i.c. experiment, mice were sacrificed in triplicate at 15 day intervals until the terminal stage, beginning from 45 days post-inoculation (pi.). Intraperitoneally inoculated mice were sacrificed in triplicate at 200, 230, 260, 280 days p.i. and additionally at about 315 days p.i. for the terminal stage of 4PB1. The sacrifice was performed by cervical column disruption and the brain was immediateIy removed. Brains were frozen in liquid nitrogen for molecular analysis, except for one hemisphere in each group which was fixed in 10 % PBSbuffered formalin for pathological examination.
• Titration experiment. An endpoint titration was performed for both inocula used in this study. Mice were inoculated by i.c. route with serial dilutions of the inocula (20,1), ranging from 10 -2 to 10 -1°. Ten mice were inoculated per dilution. The titre was determined by the calculation of the LDs0 with the formula of Reed & Muench (1938) .
• Western blot procedure. Whole brain hemispheres were homogenized at 20% in a 5% glucose solution. PrP r~ was purified with a scrapie-associated fibril (SAF) protocol previously reported (Kascsak et aI., I985), using I0 i~g/ml of proteinase K for 1 h at 37 °C (where no degradation of PrP ~s from both sources occurred). Purified preparations were resuspended in Laemmli buffer (Laemmli, I970) . Samples equivalent to 5 mg of brain were run on a I2 % polyacrylamide gel and transferred onto a nitrocellulose membrane (Schleicher & Schuell). Immunoblotting was performed with a polyclonal anti-mouse PrP antibody (1/5000) kindly provided by R. J. Kascsak (NYS Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA) and a monoclonal anti-sheep GFAP antibody (1/500) kindly provided by B. Delpech (Rouen, France). Secondary antibodies (peroxidase-conjugated goat anti-rabbit Ig or rabbit anti-mouse Ig; Southern Biotechnology) were used at 1/2500. Immunoreactivity was revealed with a chemiluminescence enhancement kit (ECL; Amersham), quantified with a radio imager (Bio-Rad) and visualized on autoradiographic films. The linearity of the detected signal intensities was verified on each electrophoresis gel by means of a dilution scale of the positive control (scrapie brain at terminal stage; Fig. 1 ). Each value obtained with the radio imager for one given signal intensity was compared with the dilution scale of the positive control and expressed as a percentage of positive control.
• Histopathological procedure. After formalin fixation, the hemisphere was cut coronally and embedded in celloidin. Sections (20~m) were stained with haematoxylin and eosin.
Results

Titres and incubation times
The titres for the scrapie and the BSE strain were respectively 10 H LD.s0/g and 109a LDs0/g of brain. Since a titre difference less than I log is usually not considered to be significant in these in vivo assays, we considered that a similar amount of agent had been inoculated to the mice in each model. The incubation times, expressed in days p.i. + sD, were 171-t-3"2 for the C506M3 strain and 181-t-5"4 for the 4PB1 strain by i.c. route and 276 + 11"8 for the C506M3 strain and 315 4-27"3 for the 4PB1 strain by i.p. route. None of the sham-infected mice exhibited any neurological signs throughout the course of the study or presented detectable PrP res (Fig. 2) . 
PrP" quantification
GFAP quantification
(i) lntracerebral inoculation. There were few variations in baseline GFAP level at the early stages of infection. GFAP began to increase at 105 days p.i. in scrapie brains, whereas it was slightly elevated at 135 days p.i. in BSE brains. Comparing the two models, the sequence of events was inverted as regards PrP res, the accumulation of which started slightly earlier in the BSE model. In fact, in each model, GFAP started to accumulate when PrP r~s had risen to at least 7% of the positive control. At the terminal stage, GFAP level was 20-fold over baseline in the scrapie model and 8-fold in the BSE model.
(ii) Intraperitoneal inoculation. In the scrapie model, GFAP began to increase at 230 days p.i., which again coincided with a PrP res amount over 7% of control. Then, the increase paralleled that of PrP res, reaching 7"5 times the baseline at terminal stage. In the BSE model, GFAP was slightly over the baseline at 260 days p.i. and then increased to four times the baseline at terminal stage.
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Histopathology
For the sake of clarity, the severity of vacuolation has been scored (from 0 to 5) in eight grey matter regions. Table I gives the distribution of lesions in mice inoculated with each inoculum i.c. or i.p., at the time when conspicuous vacuolation was first seen in several regions, and at terminal stage.
Briefly, vacuolation was prominent in the medulla and pons/mesencephalon in the BSE model ( Fig. 5 ) and the first lesions were observable at 135 days p.i.. In the scrapie model, lesions were intense in all the scored regions except the medulla and the colliculi (Figs 5 and 6) . At 120 days p.i., a few vacuoles were already observable in the hippocampus, the thalamus and scarcely in the cortex.
It is noteworthy that the pathology was first seen in those regions where the lesions were the most severe at terminal stage of disease.
After i.p. inoculation, the lesions had the same distribution as that seen with the i.c. route, but they were less intense, especially in the scrapie model. Some vacuoles were first seen at 260 days p.i. in the BSE mode[ and at 230 days p.i. in the scrapie model.
Discussion
It has been shown that, in a given PrP genotype, the distribution of vacuolar degeneration and PrP res accumulation depends on the scrapie strain (Bruce et al., I989, 1991) and is not mediated by a differential expression of PrP mRNA (Manson et al., 1992) .
On the basis of these data, we studied the time course of molecular and pathological events at a quantitative level to try to highlight the pathogenic mechanisms which are common to the BSE and the scrapie models studied and to what extent cases (Fig. 7) and there was a strong correlation between the intensity of vacuolation and PrP res amounts throughout the course of the disease. In addition, at terminal stage of the i.c. infection, pathology was significantly milder in BSE and was accompanied by a fourfold lower level of PrP res. It has been described in mouse scrapie models that brain pathology is milder after i.p. infection than i.c. infection (Fraser, I976) . The scrapie model we have studied fulfilled this criterion, whereas it was less obvious in the BSE model (Table I) , underlining the interest in comparing different models. Besides, the difference of PrP res level at terminal stage between both inoculation routes was much more important in the scrapie model than in the BSE model (Figs 3 and 4) , which again shows a quantitative link between PrP res accumulation and the level of neuronal vacuolation. These temporal and quantitative data complete previous topographical findings and emphasize the causeeffect relationship between PrP res accumulation and vacuolation (Bolton et aI., 1991; Bruce ef aI., 1989; DeArmond & Prusiner, 1995) . The analysis of the temporal sequence of PrP res and GFAP accumulation showed that the onset of GFAP increase was dependent upon PrP res level in the brain and not upon the time point of appearance of PrP res. By i.c. route, there was a I5 day delay between the two in the scrapie model and a 60 day delay in the BSE model. In the former model, PrP res increased exponentially as soon as it was detectable, whereas in the latter, the gradient of PrP res rise was much less steep. Interestingly, the slope of PrP res rise is also very steep in the hamster scrapie model, where the delay between PrP res and GFAP increase is no longer than I5 days, as in our mouse scrapie model (DeArmond et al., 1989; Jendroska et al., 1991) .
These results indicate that the onset of GFAP hyperexpression does not depend upon a general timing ruling the course of the disease and suggest that it is triggered by the accumulation of PrP res over a given threshold. This threshold seems to be around 7 to 10% of the positive control, as it can be assessed in both models with the i.c. route and in the scrapie model with the i.p. route. This strongly suggests a toxic role of PrP res accumulation in the brain, leading to the astrocytic activation observed in TSE.
The following hypotheses can be envisaged: (i) PrP resinduced astrocytic activation mediates neuronal toxicity and vacuolar changes; (ii) Infection of neurons with the agent generates PrP res, which exhibits neuronal toxicity. It has been demonstrated in vitro that synthetic peptides derived from the hydrophobic domain of PrP and purified PrP res induce the death of neuronal cells in culture (Forloni et al., 1993 ; Mfiller et al., 1993) . Neuronal damage is sufficient to induce astrogliosis (Eng et al., 1992; Le Prince eta] ., 1993); (iii) PrP res released by the infected neurons directly activates astrocytes and exerts neuronal toxicity. PrP res is able to induce GFAP hyperexpression in cultured astrocytes in vitro (unpublished results and Forloni et al., 1994) . Mediators likely to be produced by activated astrocytes could contribute to neuronal alteration, which would in turn increase gliosis.
We prefer the latter hypothesis, because the time course of events (Fig. 7) shows that the onset of GFAP increase never occurs after neuronal vacuolation and that in the majority of cases both events occur concomitantly.
However, the two models of TSE tested here differed by a number of parameters. Concerning the distribution of lesions, the C506M3 scrapie strain induced severe lesions widely distributed in the brain, with the medulla being almost spared. On the contrary, the medulla was severely involved, together with the pons and the hippocampus, in the pathology of 4PB1 BSE strain. The distribution of lesions is quite variable in natural sheep scrapie, making impossible any comparison with the murine models of scrapie. However, in BSE, the lesion pattern in cattle shows a remarkable uniformity, with a consistent caudo-rostral decrease in severity of lesions in the brain, and a mild involvement of the cortical areas (Wells & Wilesmith, 1995) , strikingly similar to our murine BSE model. This distribution is also close to the lesion profile of cattle BSE in the C57BL/6 mouse at first passage (Fraser et a[., 1992) .
The close resemblance between the distribution of pathology in natural and experimental BSE is consistent with the great stability of the BSE agent at interspecies passage. Indeed, the lesion profile of BSE in the mouse is the same whether the agent originates directly from cattle, from accidental transmissions to the cat, kudu and nyala, or from experimental transmissions to the sheep, goat and pig (Bruce et al., 1994) .
Concerning the intensity of lesions, if we consider the whole brain, the pathology was milder in BSE than in scrapie, with only one region being severely vacuolated instead of six in scrapie (i.c. route).
In spite of similar infectivity titres, the two models also differed in the amounts of PrP res and GFAP that had accumulated at termina] stage. There was fourfold and threefold more PrP res in scrapie than in BSE by i.c. and i.p. routes respectively, and twice as much GFAP in scrapie, whatever the inoculation route.
In addition, the astrocytic activation relative to PrP res seemed to be more important in the BSE model than in the scrapie. GFAP increase exceeded the PrP res in BSE since 150 clays p.i. with i.c. route, and with i.p. route, GFAP increase preceded the major PrP res rise.
To summarize, we found major differences between the two models: the severity and distribution of lesions, the concentration of PrP res and GFAP in the brains, and the severity of gliosis as compared to the amount of PrP res (which was greater in the BSE model).
This study strongly suggests that, in the two TSE models studied, the major molecular and pathological hallmarks of infection are directly due to the accumulation, to a defined 60;
On: Wed, 27 Mar 2019 22:11:26 threshold, of the abnormal isoform of the same PrP synthesized by the syngeneic mice. It confirms data obtained in vitro about the neurotoxic and astroglial effects of PrP res (Forloni et al., 1994 ; M/,iller et a]., I993). Besides, several lines of evidence indicate that normal PrP is required for PrP res to exert its toxicity (Brandner et al., 1996 , Brown et al., 1994 . The neurodegenerative processes triggered by PrP res seem to be identical in both models and may share common features with those occurring in other diseases linked to the accumulation of an amyloid protein, such as Alzheimer's disease. Nevertheless, we also observed well differentiated pathological and molecular features. Their molecular basis, which is the key of strain specificity, remains theoretical. It may be the PrP res by itself, as postulated by the prion hypothesis (DeArmond & Prusiner, 1993) . It has recently been shown that a nucleation model may explain the strain-specific properties of the structure and the rate of formation of PrP res (Bessen et al., 1995) . However, there is no experimental evidence accounting for the strain-specific targeting. Therefore, it has to be considered that there may exist an informational molecule associated with PrP res, responsible for lesion targeting, for the modulation of the interactions between PrP res and the different cell populations and the specific kinetics of PrP res and GFAP accumulation.
